Stockholders' Equity (Details) - USD ($)		1 Months Ended			12 Months Ended
	Feb. 01, 2020	Jul. 21, 2021	Apr. 20, 2020	Dec. 31, 2016	Dec. 31, 2021	Dec. 31, 2020
Stockholders' Equity (Details) [Line Items]
Common stock, authorized					50,000,000	50,000,000
Common stock, issued					16,694,311	16,564,311
Common stock,outstanding					16,617,274	16,491,103
Initial public offering term				3 years
Warrant exercise price (in Dollars per share)					$ 6.75
Restricted stock issued	35,000	130,000
Fair value of per share (in Dollars per share)	$ 4.11	$ 3.84
Vesting period	4 years	3 years
Restricted vest percentage	25.00%	25.00%
Restricted grant percentage		25.00%
Reduction of stock compensation expense value forfeited (in Dollars)					$ 0	$ 0
Unrecognized stock compensation expense (in Dollars)						403
Recognized over weighted average					2 years 3 months 3 days
Employee Benefits and Share-based Compensation (in Dollars)			$ 1,022,785		$ 415,000	386,000
Stock options intrinsic value (in Dollars)					$ 382,000	$ 0
Treasury stock					77,037	73,208
2016 Equity Incentive Plan [Member]
Stockholders' Equity (Details) [Line Items]
Number of authorized shares under the plan					397,473
2017 Equity Incentive Plan [Member]
Stockholders' Equity (Details) [Line Items]
Number of authorized shares under the plan					500,000
Initial Public Offering [Member]
Stockholders' Equity (Details) [Line Items]
Number of warrant outstanding				2,300,000
Warrant exercise price (in Dollars per share)				$ 6.75
Underwriters description					In addition, the underwriters of the IPO received four-year warrants to purchase up to 138,000 units, consisting of one share of common stock and one warrant to purchase one share of common stock. The warrants, with an exercise price of $6.75 per unit, expired on June 2, 2021.
Number of warrant granted					138,000